JPS6129928B2 - - Google Patents

Info

Publication number
JPS6129928B2
JPS6129928B2 JP52094807A JP9480777A JPS6129928B2 JP S6129928 B2 JPS6129928 B2 JP S6129928B2 JP 52094807 A JP52094807 A JP 52094807A JP 9480777 A JP9480777 A JP 9480777A JP S6129928 B2 JPS6129928 B2 JP S6129928B2
Authority
JP
Japan
Prior art keywords
amino acid
salt
acid salt
carboxylic acid
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52094807A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5428828A (en
Inventor
Akira Endo
Akira Terahara
Kunitoshi Kitano
Akira Ogiso
Seiji Mitsui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP9480777A priority Critical patent/JPS5428828A/ja
Priority to US05/847,044 priority patent/US4137322A/en
Priority to DE2748825A priority patent/DE2748825C2/de
Priority to NLAANVRAGE7712106,A priority patent/NL186001C/xx
Priority to FR7732927A priority patent/FR2369241A2/fr
Priority to GB45661/77A priority patent/GB1555831A/en
Priority to CH1332077A priority patent/CH640210A5/de
Publication of JPS5428828A publication Critical patent/JPS5428828A/ja
Priority to CH577082A priority patent/CH642939A5/de
Priority to CH523683A priority patent/CH643806A5/de
Publication of JPS6129928B2 publication Critical patent/JPS6129928B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06—Aluminium compounds
    • C07F5/069—Aluminium compounds without C-aluminium linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP9480777A 1976-11-02 1977-08-08 Remedy for hyperlipemia mainly composed of ml-236b carboxylic acid amino acid salt Granted JPS5428828A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP9480777A JPS5428828A (en) 1977-08-08 1977-08-08 Remedy for hyperlipemia mainly composed of ml-236b carboxylic acid amino acid salt
US05/847,044 US4137322A (en) 1976-11-02 1977-10-31 ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents
DE2748825A DE2748825C2 (de) 1976-11-02 1977-10-31 Substituierte 3,5-Dihydroxyheptansäurederivate und diese enthaltende Arzneimittel gegen Hyperlipämie
GB45661/77A GB1555831A (en) 1976-11-02 1977-11-02 Carboxylic containing hexahydronaphthalene derivatives having antihyoerlipaemic activity
FR7732927A FR2369241A2 (fr) 1976-11-02 1977-11-02 Nouvelles substances a action physiologique deriv
NLAANVRAGE7712106,A NL186001C (nl) 1976-11-02 1977-11-02 Werkwijze ter bereiding van een farmaceutisch preparaat voor de behandeling van hyperlipemie, aldus verkregen gevormd geneesmiddel, alsmede werkwijze ter bereiding van een voor een dergelijk preparaat geschikte fysiologisch werkzame stof.
CH1332077A CH640210A5 (en) 1977-08-08 1978-01-01 ML-236B carboxylic acid derivatives and compositions for the treatment of hyperlipaemia
CH577082A CH642939A5 (de) 1976-11-02 1982-09-30 Verfahren zur herstellung neuer ml-236b-carbonsaeurederivate mit antihyperlipaemischer wirksamkeit.
CH523683A CH643806A5 (de) 1976-11-02 1983-09-27 Verfahren zur herstellung neuer ml-236b-carbonsaeurederivate.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9480777A JPS5428828A (en) 1977-08-08 1977-08-08 Remedy for hyperlipemia mainly composed of ml-236b carboxylic acid amino acid salt

Publications (2)

Publication Number Publication Date
JPS5428828A JPS5428828A (en) 1979-03-03
JPS6129928B2 true JPS6129928B2 (enrdf_load_stackoverflow) 1986-07-10

Family

ID=14120318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9480777A Granted JPS5428828A (en) 1976-11-02 1977-08-08 Remedy for hyperlipemia mainly composed of ml-236b carboxylic acid amino acid salt

Country Status (2)

Country Link
JP (1) JPS5428828A (enrdf_load_stackoverflow)
CH (1) CH640210A5 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6389826U (enrdf_load_stackoverflow) * 1986-12-02 1988-06-10

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123140A (en) * 1981-01-23 1982-07-31 Sankyo Co Ltd Ml-236b carboxylic acid amine salt and remedy for hyperlipemia containing said salt as active component
JPS5855418A (ja) * 1981-09-25 1983-04-01 Akira Endo 高脂血症治療剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6389826U (enrdf_load_stackoverflow) * 1986-12-02 1988-06-10

Also Published As

Publication number Publication date
JPS5428828A (en) 1979-03-03
CH640210A5 (en) 1983-12-30

Similar Documents

Publication Publication Date Title
KR101722289B1 (ko) 피부과 질환 또는 증상의 치료에 유용한 ｔｏｆａ 유사체
DE60307607T2 (de) Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten
JPS6144868B2 (enrdf_load_stackoverflow)
US4325974A (en) β, γ-Dihydropolyprenyl alcohol and hypotensive pharmaceutical composition containing same
KR100266834B1 (ko) 프로스타글란딘 유도체
WO2018106928A1 (en) Treatment and prevention of hbv diseases by cyclosporine analogue molecules modified at amino acides 1 and 3
EA014101B1 (ru) Антагонист cd80
JPS6129928B2 (enrdf_load_stackoverflow)
JPS6011024B2 (ja) 新規アミノ酸誘導体の製法
JPS6026094B2 (ja) テトラヒドロｍｌ↓−２３６ｂおよびその誘導体並びにそれを有効成分とする高脂血症治療剤
JP2567593B2 (ja) イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
JPS6232170B2 (enrdf_load_stackoverflow)
JPS5817443B2 (ja) Ｍｌ−２３６ｂ金属塩を主成分とする高脂血症治療剤
US6613937B2 (en) S-nitroso- and S-nitro-N-acyl-L-cysteine ester derivatives as pharmalogically active agents and pharmaceutical compositions containing said compounds
CN104356120B (zh) 多取代喹啉类他汀内酯脱水化合物及其用途
JPH04230628A (ja) 脂質調節薬としての１０員環ラクトンの使用
US20030144345A1 (en) Treatment of metabolic diseases with soraphen derivatives
US3968247A (en) Substituted or unsubstituted p-alkanoyl toluenes as anti-diabetic agents
CN105017230B (zh) 多取代喹啉类他汀含氟衍生物及其用途
CN104311517B (zh) 他汀内酯脱水化合物及其用途
JP3061445B2 (ja) 血管拡張剤
WO2005005433A1 (ja) 高カルシウム血症および骨疾患治療剤
WO2024011238A2 (en) Compounds, compositions, and methods for reducing production of trimethylamine
US3824315A (en) Method of treatment
WO2004014427A1 (ja) 血液脂質を低下させるための医薬組成物